Westside Investment Management’s BioNTech BNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.3K Hold
100
﹤0.01% 1136
2026
Q1
$9.12K Hold
100
﹤0.01% 1126
2025
Q4
$9.67K Hold
100
﹤0.01% 1095
2025
Q3
$10.2K Hold
100
﹤0.01% 1091
2025
Q2
$10.8K Hold
100
﹤0.01% 906
2025
Q1
$9.03K Hold
100
﹤0.01% 696
2024
Q4
$11.4K Hold
100
﹤0.01% 664
2024
Q3
$8.07K Hold
100
﹤0.01% 715
2024
Q2
$8.04K Hold
100
﹤0.01% 693
2024
Q1
$9.31K Buy
+100
New +$9.59K ﹤0.01% 641

Other funds holding BNTX

Westside Investment Management's BNTX Position: Q2 2026 in Review

Westside Investment Management held its BioNTech (BNTX) position steady in Q2 2026 at 100 shares worth $9.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1136.

Westside Investment Management first reported a position in BNTX in Q1 2024 and has held it in 10 quarters since. The position peaked at $11.4K in Q4 2024. 282 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • Westside Investment Management held 100 shares of BioNTech worth $9.3K as of Q2 2026.
  • Westside Investment Management left its BioNTech share count unchanged in Q2 2026.
  • BioNTech made up ﹤0.01% of Westside Investment Management's portfolio in Q2 2026, its #1136 holding.
  • Westside Investment Management first reported a position in BioNTech in Q1 2024 and has held it in 10 quarters since.
  • Westside Investment Management's BioNTech position peaked at $11.4K in Q4 2024.
  • 282 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Westside Investment Management's 13F filing for Q2 2026, filed 27 Jul 2026.